SummaryXTENT, Inc. (XTENT), a development stage medical device company is engaged in the design and manufacture of customizable drug-eluting stent (DES) systems for the treatment of coronary artery disease. The company's customizable DES systems help to enable the treatment of single, multiple and long with one device. It has multiple studies underway to evaluate its Custom NX DES platform. The company's stent systems, include, the Custom NX 36 and the Custom NX 60 and in addition, its stents have drug coating of Biolimus A9, an anti-inflammatory drug, and PolyLactic Acid, a biodegradable polymer. Additionally, it also provides XTENT solutions such as CAD stent, drug coating and stent delivery sysGlobal Markets Direct's XTENT, Inc. - Financial Analysis Review is an in-depth business, financial analysis of XTENT, Inc.. The report provides a comprehensive insight into the company, including business structure and operations, executive biographies and key competitors. The hallmark of the report is the detailed financial ratios of the companyScope- Provides key company information for business intelligence needs The report contains critical company information ' business structure and operations, the company history, major products and services, key competitors, key employees and executive biographies, different locations and important subsidiaries.- The report provides detailed financial ratios for the past five years as well as interim ratios for the last four quarters.- Financial ratios include profitability, margins and returns, liquidity and leverage, financial position and efficiency ratios.Reasons to buy- A quick 'one-stop-shop' to understand the company.- Enhance business/sales activities by understanding customers' businesses better.- Get detailed information and financial analysis on companies operating in your industry.- Identify prospective partners and suppliers ' with key data on their businesses and locations.- Compare your company's financial trends with those of your peers / competitors.- Scout for potential acquisition targets, with detailed insight into the companies' financial and operational performance.KeywordsXTENT, Inc.,Financial Ratios, Annual Ratios, Interim Ratios, Ratio Charts, Key Ratios, Share Data, Performance, Financial Performance, Overview, Business Description, Major Product, Brands, History, Key Employees, Strategy, Competitors, Company Statement,

1. Find Industry reports, Company profiles
ReportLinker and Market Statistics
>> Get this Report Now by email!
XTENT, Inc. - Financial Analysis Review
Published on August 2009
Report Summary
Summary
XTENT, Inc. (XTENT), a development stage medical device company is engaged in the design and manufacture of customizable
drug-eluting stent (DES) systems for the treatment of coronary artery disease. The company's customizable DES systems help to
enable the treatment of single, multiple and long with one device. It has multiple studies underway to evaluate its Custom NX DES
platform. The company's stent systems, include, the Custom NX 36 and the Custom NX 60 and in addition, its stents have drug
coating of Biolimus A9, an anti-inflammatory drug, and PolyLactic Acid, a biodegradable polymer. Additionally, it also provides XTENT
solutions such as CAD stent, drug coating and stent delivery sys
Global Markets Direct's XTENT, Inc. - Financial Analysis Review is an in-depth business, financial analysis of XTENT, Inc.. The report
provides a comprehensive insight into the company, including business structure and operations, executive biographies and key
competitors. The hallmark of the report is the detailed financial ratios of the company
Scope
- Provides key company information for business intelligence needs
The report contains critical company information ' business structure and operations, the company history, major products and
services, key competitors, key employees and executive biographies, different locations and important subsidiaries.
- The report provides detailed financial ratios for the past five years as well as interim ratios for the last four quarters.
- Financial ratios include profitability, margins and returns, liquidity and leverage, financial position and efficiency ratios.
Reasons to buy
- A quick 'one-stop-shop' to understand the company.
- Enhance business/sales activities by understanding customers' businesses better.
- Get detailed information and financial analysis on companies operating in your industry.
- Identify prospective partners and suppliers ' with key data on their businesses and locations.
- Compare your company's financial trends with those of your peers / competitors.
- Scout for potential acquisition targets, with detailed insight into the companies' financial and operational performance.
Keywords
XTENT, Inc.,Financial Ratios, Annual Ratios, Interim Ratios, Ratio Charts, Key Ratios, Share Data, Performance, Financial
Performance, Overview, Business Description, Major Product, Brands, History, Key Employees, Strategy, Competitors, Company
Statement,
Table of Content
XTENT, Inc. - Financial Analysis Review Page 1/4

2. Find Industry reports, Company profiles
ReportLinker and Market Statistics
Table Of Contents
Key Information 1
Key Ratios 1
Performance Chart 1
Table Of Contents 2
List of Tables 2
List of Figures 2
Key Facts 3
Company Overview 3
Major Products and Services 3
Overview 3
Key Competitors 4
Key Employees 4
Locations And Subsidiaries 4
Head Office 4
Financial Ratios 5
Capital Market Ratios 5
Annual Ratios 5
Interim Ratios 5
Ratio Charts 6
Appendix 7
Methodology 7
Ratio Definitions 7
About Global Markets Direct 10
Contact Us 10
Disclaimer 10
List of Tables
XTENT, Inc., Key Facts 1
XTENT, Inc., Key Ratios 1
XTENT, Inc., Key Facts 3
XTENT, Inc., Key Employees 4
XTENT, Inc., Ratios based on current share price 5
XTENT, Inc., Annual Ratios 5
XTENT, Inc., Interim Ratios 5
Currency Codes 7
Capital Market Ratios 7
Equity Ratios 7
Profitability Ratios 8
Cost Ratios 8
Liquidity Ratios 9
Leverage Ratios 9
Efficiency Ratios 9
List of Figures
XTENT, Inc., Performance Chart (2004 - 2008) 1
XTENT, Inc., Ratio Charts 6
XTENT, Inc. - Financial Analysis Review Page 2/4

3. Find Industry reports, Company profiles
ReportLinker and Market Statistics
Fax Order Form
To place an order via fax simply print this form, fill in the information below and fax the completed form to:
Europe, Middle East and Africa : + 33 4 37 37 15 56
Asia, Oceania and America : + 1 (805) 617 17 93
If you have any questions please visit http://www.reportlinker.com/notify/contact
Order Information
Please verify that the product information is correct and select the format(s) you require.
XTENT, Inc. - Financial Analysis Review
Product Formats
Please select the product formats and the quantity you require.
Digital Copy--USD 125.00 Quantity: _____
Contact Information
Please enter all the information below in BLOCK CAPITALS
Title: Mr Mrs Dr Miss Ms Prof
First Name: _____________________________ Last Name: __________________________________
Email Address: __________________________________________________________________________
Job Title: __________________________________________________________________________
Organization: __________________________________________________________________________
Address: __________________________________________________________________________
City: __________________________________________________________________________
Postal / Zip Code: __________________________________________________________________________
Country: __________________________________________________________________________
Phone Number: __________________________________________________________________________
Fax Number: __________________________________________________________________________
XTENT, Inc. - Financial Analysis Review Page 3/4

4. Find Industry reports, Company profiles
ReportLinker and Market Statistics
Payment Information
Please indicate the payment method, you would like to use by selecting the appropriate box.
Payment by credit card Card Number: ______________________________________________
Expiry Date __________ / _________
CVV Number _____________________
Card Type (ex: Visa, Amex…) _________________________________
Payment by wire transfer Crédit Mutuel
RIB : 10278 07314 00020257701 89
BIC : CMCIFR2A
IBAN : FR76 1027 8073 1400 0202 5770 189
Payment by check UBIQUICK SAS
16 rue Grenette – 69002 LYON, FRANCE
Customer signature:
Please note that by ordering from Reportlinker you are agreeing to our Terms and Conditions at
http://www.reportlinker.com/index/terms
Please fax this form to:
Europe, Middle East and Africa : + 33 4 37 37 15 56
Asia, Oceania and America : + 1 (805) 617 17 93
XTENT, Inc. - Financial Analysis Review Page 4/4